MedTrace Logo

Clinical Trial for Prostate Cancer

NCT00076531 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2008-01-28

No results posted yet for this study

Summary

Phase III trial using an injectable for treatment of prostate cancer.

Conditions

Interventions

DRUG

Leuprolide Acetate for Injectable Suspension 22.5 mg

Sponsors & Collaborators

  • Oakwood Laboratories, LLC

    lead INDUSTRY

Principal Investigators

  • James A. Page, M.D. · Oakwood Laboratories, LLC

Study Design

Purpose
TREATMENT
Masking
NONE

Eligibility

Min Age
40 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-12-31
Primary Completion
2004-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00076531 on ClinicalTrials.gov